Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Bluejay Diagnostics, Inc. (BJDX : NSDQ)

• Company Description    Bluejay Diagnostics Inc. is a late-stage, pre-revenue medical device company. It focused on developing near-patient products for triage, diagnosis and monitoring of disease progression. Bluejay Diagnostics Inc. is based in ACTON, Mass. Number of Employees: 6

• Price / Volume Information    Yesterday's Closing Price: $0.58 Daily Weekly Monthly 20 Day Moving Average: 503,436 shares Shares Outstanding: 4.47 (millions) Market Capitalization: $2.61 (millions) Beta: 0.89 52 Week High: $9.60 52 Week Low: $0.59 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -38.42% -37.77% 12 Week -37.05% -38.59% Year To Date -78.08% -78.95%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 360 MASSACHUSETTS AVENUE SUITE 203 - ACTON,MA 01720 USA ph: 844-327-7078 fax: - ir@bluejaydx.com https://bluejaydx.com

• General Corporate Information    Officers Neil Dey - President; Chief ExecutiveOfficer and Director Donald R. Chase - Chairman of the Board of Director Douglas C. Wurth - Director Svetlana Dey - Director Fred S. Zeidman - Director Peer Information - (-) - (-) - (-) - (-) - (-) - (-) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED INSTRUMENTS Sector: Medical CUSIP: 095633608 SIC: 3841 Fiscal Year Fiscal Year End: December Last Reported Quarter: 06/01/26 Next Expected EPS Date: 11/06/26 Share - Related Items Shares Outstanding: 4.47 Most Recent Split Date: 1.00 (0.25:1) Beta: 0.89 Market Capitalization: $2.61 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio: Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 11/06/26

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 0.12 Price/Cash Flow: - Price / Sales: - EPS Growth vs. Year Ago Period: 80.14% vs. Previous Quarter: 42.56% Sales Growth vs. Year Ago Period: -% vs. Previous Quarter: -% ROE 09/30/26 - - 06/30/26 - -125.00 03/31/26 - -144.27 ROA 09/30/26 - - 06/30/26 - -99.79 03/31/26 - -115.00 Current Ratio 09/30/26 - - 06/30/26 - 4.64 03/31/26 - 2.81 Quick Ratio 09/30/26 - - 06/30/26 - 4.64 03/31/26 - 2.81 Operating Margin 09/30/26 - - 06/30/26 - - 03/31/26 - - Net Margin 09/30/26 - - 06/30/26 - - 03/31/26 - - Pre-Tax Margin 09/30/26 - - 06/30/26 - - 03/31/26 - - Book Value 09/30/26 - - 06/30/26 - 4.75 03/31/26 - 4.04 Inventory Turnover 09/30/26 - - 06/30/26 - - 03/31/26 - - Debt-to-Equity 09/30/26 - - 06/30/26 - 0.00 03/31/26 - 0.00 Debt-to-Capital 09/30/26 - - 06/30/26 - 0.00 03/31/26 - 0.00

Powered by Zacks Investment Research ©